VF
SABSW icon

Virtu Financial’s SAB Biotherapeutics Warrant SABSW Stock Holding History

Virtu Financial’s Portfolio SABSW Stock Details SABSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Buy
+21,223
New +$401 ﹤0.01% 2164

Other funds holding SABSW

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return

Virtu Financial's SABSW Position: Q2 2026 in Review

Virtu Financial opened a new position in SAB Biotherapeutics Warrant (SABSW) in Q2 2026: 21,223 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #2164 among its holdings.

5 funds tracked by Wall St. Rank hold SABSW as of Q2 2026.

  • Virtu Financial held 21,223 shares of SAB Biotherapeutics Warrant worth $0 as of Q2 2026.
  • SAB Biotherapeutics Warrant was a new Virtu Financial position in Q2 2026.
  • SAB Biotherapeutics Warrant made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #2164 holding.
  • 5 funds tracked by Wall St. Rank held SAB Biotherapeutics Warrant as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.